PHAT vs RF
Phathom Pharmaceuticals Inc (PHAT) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
RF does not have a complete income-statement cache yet.
PHAT currently screens at market cap $622.7M. RF currently screens at market cap $0.
Not investment advice. Open the PHAT and RF stock pages for the full models.
Not investment advice.